Caas Capital Management LP Vertex Pharmaceuticals Inc Transaction History
Caas Capital Management LP
- $895 Million
- Q1 2025
A detailed history of Caas Capital Management LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Caas Capital Management LP holds 100 shares of VRTX stock, worth $45,941. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100Holding current value
$45,941% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,836Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$13.1 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.79 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.68 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.42 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $118B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...